Skip to main content
Clinical Trials/ACTRN12624000483550
ACTRN12624000483550Not yet recruitingUnknown

Application of a clinical support tool in active surveillance for low risk thyroid cancer

Department of Endocrinology, Royal North Shore Hospital0 sites80 target enrollmentStarted: April 19, 2024Last updated:
Conditions

Trial Snapshot

Phase
Unknown
Status
Not yet recruiting
Sponsor
Enrollment
80

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Randomised controlled trial
Primary Purpose
Treatment

Eligibility Criteria

Ages
18 Years to o limit (—)
Sex
All

Inclusion Criteria

  • •Participants will be eligible for inclusion in the study if all of the below are met:
  • •Age 18 or above
  • •Thyroid nodule 2cm or smaller
  • •Bethesda III, V or Bethesda VI result on FNA cytopathology
  • •Clinicians will be eligible for inclusion if they are involved in the treatment of patients with thyroid cancer.

Exclusion Criteria

  • •Participants will be excluded from study if:
  • •Thyroid nodule >2cm in size
  • •Bethesda result other than BIII, BV or BVI
  • •If they are unable to provide informed consent

Investigators

Sponsor
Department of Endocrinology, Royal North Shore Hospital

Similar Trials